HealOr appoints new CEO
HealOr is a developer of new treatments for acute and chronic wounds such as diabetic foot ulcer (DFU), psoriasis and others. Most recently, Sabolinski has worked as the
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.